|
|||||
|
|
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor |
|
| Affiliation: | 1. Pfizer Global Research and Development La Jolla, 10770 Science Center Drive, San Diego, CA 92121, USA |
| Abstract: |  |
| Keywords: | CDK2 cell cycle hormone-receptor-positive breast cancer MYC therapy resistance innate immune response palbociclib CCNE1 CDK4 CDK6 |
| 本文献已被 ScienceDirect 等数据库收录！ | |